Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes

Overview of attention for article published in Cardiovascular Diabetology, February 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 4,348 followers.

【SGLT2阻害薬に内皮再生増強の可能性？/ Cardiovasc Diabetol】米国、２型DM 29例ランダム化：SGLT2阻害薬16週間で、プラセボに比べ、血管内皮前駆細胞の遊走能が増加。 https://t.co/oHJY9sihYv

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.